0 0 Chemicalname=LOXO-101 (ARRY-470),LOXO-101 (ARRY-470),CAS=CAS=1223403-58-4Molecular formula=C21H22F2N6O2 | CLEARSYNTH

LOXO-101 (ARRY-470)

INHIBITORS

Product Details

CAT No.# CS-AV-00094
Category Inhibitors
CAS 1223403-58-4
Molecular Weight 428.44
Molecular Formula C21H22F2N6O2
Purity: >98
Synonyms: Larotrectinib
Application Notes: NA
References: Julia Haas, Steven W. Andrews, Yutong Jiang, Gan Zhang, Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors and their preparation and use in the treatment of diseases. WO2010048314 (2010).
Storage: (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
Shipping: Free Shipping for worldwide on order above 2000 USD
LOXO-101 (ARRY-470) Worldwide Suppliers of LOXO-101 (ARRY-470) Inhibitors Clearsynth CS-AV-00094

Product rating: 9 LOXO-101 (ARRY-470) based on 20 ratings

  1. Inhibitors
  2. LOXO-101 (ARRY-470)

PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Crisaborole m-Isomer
15. Riluzole (1604337)
16. Pheniramine impurity B
17. Palbociclib N-Glucuronide
18. Carpropamid
19. Olmesartan N1-Trityl Impurity
20. Aripiprazole (1042634)


Smileys:
O=C(N1CC[C@@H](C1)O)NC2=C3N=C(N4CCC[C@@H]4C5=CC(F)=CC=C5F)C=CN3N=C2



This page contains information about LOXO-101 (ARRY-470) Cas 1223403-58-4 and its Inhibitors.

LOXO-101 (ARRY-470) LOXO-101 (ARRY-470) Worldwide Suppliers of LOXO-101 (ARRY-470) Inhibitors Clearsynth 1223403-58-4

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."